Queens
Astoria
37-15 23rd Ave, Astoria, NY 11105
A western Queens option for patients who want easier access than crossing into Manhattan for every monitored treatment day.
View location detailsSafety and monitoring
At-home ketamine programs and in-clinic Spravato treatment have very different safety structures. Spravato is administered only in a certified healthcare setting with monitoring after dosing.
Multi-location Spravato access across NYC and Long Island, with care-manager support, Medicaid access, and clinic options that account for repeated monitored visits.
Spravato can cause sedation, dissociation, increased blood pressure, and other side effects that require monitoring. Patients remain in the clinic after dosing and leave only after the care team determines they are clinically stable.
The FDA has identified safety concerns related to compounded ketamine products used for psychiatric conditions, including abuse and misuse, psychiatric events, increased blood pressure, respiratory depression, and urinary or bladder symptoms. Safety concerns may be greater when treatment occurs without direct monitoring by a healthcare provider.
Clinical references reviewed: SPRAVATO REMS and the FDA prescribing information. Last reviewed May 2026. This information does not replace a clinical evaluation.
Queens
37-15 23rd Ave, Astoria, NY 11105
A western Queens option for patients who want easier access than crossing into Manhattan for every monitored treatment day.
View location detailsBronx
2063A Bartow Ave, Bronx, NY 10475
A Bronx access point for patients who want local Spravato care without leaving the borough.
View location detailsLong Island
232 W Old Country Rd, Hicksville, NY 11801
A central Nassau option for patients who need consistent follow-up, prior auth support, and a shorter commute.
View location detailsQueens
90-18 Sutphin Blvd, Jamaica, NY 11435
A southeast Queens location that helps patients stay on schedule for repeated monitored sessions.
View location detailsQueens
30-07 36th Ave, Astoria, NY 11106
A western Queens access point for patients balancing treatment days with work, home, or Manhattan commutes.
View location detailsLong Island
135 Mineola Blvd, Mineola, NY 11501
A Long Island access point for patients who want strong benefits support and reliable treatment coordination.
View location detailsManhattan
259 1st Ave, New York, NY 10003
A Manhattan Spravato access point for East Village, Gramercy, Kips Bay, and nearby neighborhoods.
View location detailsBrooklyn
308 Graham Ave, Brooklyn, NY 11211
The lead Brooklyn Spravato location for patients who want local access and ongoing psychiatric support.
View location detailsAccepted plans can vary by eligibility and authorization rules. This list reflects the insurance access Nao Medical can review for eligible Spravato patients, including Medicaid, Medicare, Medicare Advantage, and commercial coverage options.
No. Spravato is not dispensed directly to patients for home use.
Compounded ketamine products used for psychiatric conditions are not FDA-approved for those uses. Patients should discuss risks and alternatives with a qualified clinician.
Monitoring helps the care team watch for sedation, dissociation, blood pressure changes, and other side effects before a patient leaves.
Insurance and Medicaid can be reviewed for eligible patients. Coverage depends on benefits, diagnosis, authorization, and plan rules.